Autor/in Moehler, M Al-Batran, S-E 1 Andus, T 1 Anthuber, M 1 Arends, J 1 Arnold, Dirk 1 Aust, D 1 Baier, P 1 Baretton, G 1 Baron, A 1 Bernhardt, J 1 Boeing, H 1 Byun, K S 1 Chao, Y 1 Denzer, Ulrike 1 Distelrath, A 1 Ebert, M P 1 Geissler, M 1 Heo, J 1 Jonker, D 1 Kanzler, S 1 Kolligs, F T 1 Lee, H C 1 Maderer, A 1 Paik, S W 1 Schimanski, C 1 Schütz, M 1 Tak, W Y 1 Trojan, J 1 Ungerechts, G 1 Yim, H J 1 alle zeigenListe einklappen
Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE) Moehler, M Heo, J Lee, H C Tak, W Y Chao, Y Paik, S W Yim, H J 2019 - Forschungsinformationssystem des UKE - frei zugänglich
Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme Moehler, M Maderer, A Schimanski, C Kanzler, S Denzer, Ulrike Kolligs, F T Ebert, M P 2014 - Forschungsinformationssystem des UKE
German S3-Guideline „Diagnosis and Treatment of Esophagogastric Cancer”, S3-Leitlinie „Magenkarzinom”:Diagnostik und Therapie der Adenokarzinome des Magens und ösophagogastralen Übergangs (AWMF-Regist.-Nr. 032-009-OL) Moehler, M Al-Batran, S-E Andus, T Anthuber, M Arends, J Arnold, Dirk Aust, D 2011 - Forschungsinformationssystem des UKE